655 related articles for article (PubMed ID: 16297142)
21. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
Ferdousi HA; Dreborg S
Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
[TBL] [Abstract][Full Text] [Related]
22. Extrathoracic airway responsiveness in children with asthma-like symptoms, including chronic persistent cough.
Turktas I; Dalgic N; Bostanci I; Cengizlier R
Pediatr Pulmonol; 2002 Sep; 34(3):172-80. PubMed ID: 12203845
[TBL] [Abstract][Full Text] [Related]
23. Body mass index, respiratory function and bronchial hyperreactivity in allergic rhinitis and asthma.
Ciprandi G; Pistorio A; Tosca M; Ferraro MR; Cirillo I
Respir Med; 2009 Feb; 103(2):289-95. PubMed ID: 18818065
[TBL] [Abstract][Full Text] [Related]
24. Bronchial hyperresponsiveness in children with atopic rhinitis: a 7-year follow-up.
Cibella F; Cuttitta G; La Grutta S; Hopps MR; Passalacqua G; Pajno GB; Bonsignore G
Allergy; 2004 Oct; 59(10):1074-9. PubMed ID: 15355466
[TBL] [Abstract][Full Text] [Related]
25. Exhaled nitric oxide, bronchial hyperresponsiveness and spirometric parameters in patients with allergic rhinitis during pollen season.
Makris MP; Gratziou C; Aggelides XS; Koulouris SP; Koti I; Kalogeromitros DC
Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):251-60. PubMed ID: 22184267
[TBL] [Abstract][Full Text] [Related]
26. Exhaled nitric oxide in evaluation of young adults with chronic cough.
Kowal K; Bodzenta-Lukaszyk A; Zukowski S
J Asthma; 2009 Sep; 46(7):692-8. PubMed ID: 19728207
[TBL] [Abstract][Full Text] [Related]
27. Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness.
Tufvesson E; Aronsson D; Bjermer L
Clin Exp Allergy; 2007 Jul; 37(7):1067-73. PubMed ID: 17581201
[TBL] [Abstract][Full Text] [Related]
28. Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice.
Quaedvlieg V; Sele J; Henket M; Louis R
Clin Exp Allergy; 2009 Dec; 39(12):1822-9. PubMed ID: 19817755
[TBL] [Abstract][Full Text] [Related]
29. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of exhaled nitric oxide for diagnosing asthma.
Pedrosa M; Cancelliere N; Barranco P; López-Carrasco V; Quirce S
J Asthma; 2010 Sep; 47(7):817-21. PubMed ID: 20718633
[TBL] [Abstract][Full Text] [Related]
31. Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity.
Cirillo I; Pistorio A; Tosca M; Ciprandi G
Allergy; 2009 Mar; 64(3):439-44. PubMed ID: 19175597
[TBL] [Abstract][Full Text] [Related]
32. Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease?
Williamson PA; Vaidyanathan S; Clearie K; Barnes M; Lipworth BJ
Clin Exp Allergy; 2011 Oct; 41(10):1379-85. PubMed ID: 21676042
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of fitness to utilize Self-Contained Breathing Apparatus (SCBA).
Miedinger D; Bläuenstein A; Wolf N; Frey F; Karli C; Leuppi JD
J Asthma; 2010 Mar; 47(2):178-84. PubMed ID: 20170326
[TBL] [Abstract][Full Text] [Related]
34. Population-based study of multiplexed IgE sensitization in relation to asthma, exhaled nitric oxide, and bronchial responsiveness.
Patelis A; Gunnbjörnsdottir M; Malinovschi A; Matsson P; Onell A; Högman M; Alving K; Janson C
J Allergy Clin Immunol; 2012 Aug; 130(2):397-402.e2. PubMed ID: 22633327
[TBL] [Abstract][Full Text] [Related]
35. Mediators in exhaled breath condensate after hypertonic saline challenge.
Ratnawati ; Morton J; Henry RL; Thomas PS
J Asthma; 2009 Dec; 46(10):1045-51. PubMed ID: 19995145
[TBL] [Abstract][Full Text] [Related]
36. Is FENO50 useful diagnostic tool in suspected asthma?
Schleich FN; Asandei R; Manise M; Sele J; Seidel L; Louis R
Int J Clin Pract; 2012 Feb; 66(2):158-65. PubMed ID: 22257040
[TBL] [Abstract][Full Text] [Related]
37. FEF(25-75) might be a predictive factor for bronchial inflammation and bronchial hyperreactivity in adolescents with allergic rhinitis.
Ciprandi G; Tosca MA; Castellazzi AM; Cairello F; Salpietro C; Arrigo T; Miraglia Del Giudice M
Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):17-20. PubMed ID: 22032781
[TBL] [Abstract][Full Text] [Related]
38. Airway responsiveness as a direct factor contributing to the dyspnoea perception in asthma.
Koh YI; Choi IS; Lim H
Respir Med; 2001 Jun; 95(6):464-70. PubMed ID: 11421503
[TBL] [Abstract][Full Text] [Related]
39. Bronchial hyperreactivity and spirometric impairment in patients with perennial allergic rhinitis.
Ciprandi G; Cirillo I; Tosca MA; Vizzaccaro A
Int Arch Allergy Immunol; 2004 Jan; 133(1):14-8. PubMed ID: 14646374
[TBL] [Abstract][Full Text] [Related]
40. Atopic disease and exhaled nitric oxide in an unselected population of young adults.
van Asch CJ; Balemans WA; Rovers MM; Schilder AG; van der Ent CK
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):59-65. PubMed ID: 18254484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
